BioSpace News Archive

Gamida Cell Ltd. today announced eight presentations at the 2022 Transplantation & Cellular Therapy Meetings of ASTCT and CIBMTR Tandem Meetings (TCT) being held in Salt Lake City, UT, from February 2-6, 2022.

Foghorn® Therapeutics Inc. announced that Foghorn will present at the H.C. Wainwright BioConnect Conference which is being held virtually on January 10th through the 13th, 2022.

Dynavax Technologies Corporation reported that it has granted nonstatutory stock options to purchase an aggregate of 94,000 shares of Dynavax common stock and restricted stock units covering an aggregate of 2,500 shares of Dynavax common stock as inducements to 5 newly-hired employees in connection with commencement of employment with the Company.

Oxurion NV announced updates on its two clinical programs, THR-687, initially being developed for first line treatment of DME, and THR-149 being developed for second line treatment of DME.

Dental implants are metal posts or frames that are surgically placed into the jawbone underneath the gums. These implants enable the doctor to mount and hold the substitute teeth on this framework.

Meningitis is an inflammation of the defensive layers called meninges covering the brain and spinal cord.

A dental hand piece is a tool which is used to drill into specific areas of the tooth with high and low speed.

Fact.MR – A Market Research and Competitive Intelligence Provider: According to Fact.MR’s latest analysis, global medical camera sales will expand by 1.4X during the forecast period, reaching a market worth of roughly US$5 billion by 2031.

Vesicoureteral reflux treatment is the medical condition characterized by the abnormal flow of urine form the bladder to the upper urinary tract.

QIAGEN N.V. announced new additions to the growing number of applications for QIAcuity, its ultrasensitive digital PCR platform that has set new standards by using so-called nanoplates to process samples in two hours rather than the five hours required by other systems.